Back to Authors

Olson, Thomas

0000-0002-3446-0414

Mayo Clinic

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Citations 2

Sex Differences in Exercise Capacity and Outcomes Following Outpatient Cardiac Rehabilitation
Chacin‐Suarez, Audry , Taylor, Jenna L. , Fischer, Karen M. , Bonikowske, Amanda R. , Squires, Ray W. , Thomas, Randal J. , Olson, Thomas P. , Smith, Joshua R , Medina-Inojosa, José R , Chacin Suarez, Audry S , Taylor, Jenna L , Fischer, Karen M , Bonikowske, Amanda , Thomas, Randal , Olson, Thomas , Smith, Joshua R. , Medina‐Inojosa, José R.

Journal of the American Heart Association | July 17, 2026 | Volume: 15 | Issue: 14 | Pages: No page available

10.1161/jaha.125.044403 Get It

Background Cardiac rehabilitation (CR) leads to increased exercise capacity (VO 2 peak) and risk reduction of major adverse cardiovascular events (MACEs). Women exhibit blunted VO 2 peak improvements following CR. The purpose was to examine sex differences in the clinical predictors of VO 2 peak improvement and odds of MACEs following CR. Methods From 1999 to 2017, all consecutive patients undergoing cardiopulmonary exercise testing before and after CR were included. Sex differences in peak exercise metrics in response to CR were compared. Multiple logistic regression models were fit to assess clinical predictors of VO 2 peak improvement (defined as >0% from pre‐CR) and MACEs following CR for men and women. Results A total of 513 men and 158 women were included. Men had greater increases in VO 2 peak than women following CR ( P =0.001). For men, independent predictors of VO 2 peak improvement following CR included higher CR session attendance (odds ratio [OR], 1.04 [95% CI, 1.02–1.06]), peripheral artery disease (OR, 0.47 [95% CI, 0.25–0.86]), and pre‐CR VO 2 peak (OR, 0.98 [95% CI, 0.97–0.99]) (all, P <0.02). Independent predictors of lower odds of MACEs following CR in men included higher number of CR sessions (OR, 0.97 [95% CI, 0.95–0.99]), pre‐CR VO 2 peak (OR, 0.98 [95% CI, 0.97–0.99]), surgical CR indication (OR, 0.34 [95% CI, 0.18–0.68]), and no history of peripheral artery disease (OR, 2.94 [95% CI, 1.60–5.38]) (all, P <0.02). For women, the selected clinical characteristics were not statistically significant independent predictors of VO 2 peak improvement or odds of MACEs (except for diabetes) following CR. Conclusions These findings suggest that clinical predictors of VO 2 peak improvement and odds of MACEs following CR are sex specific.
Efficacy and Adherence Rates of a Novel Community‐Informed Virtual World‐Based Cardiac Rehabilitation Program: Protocol for the Destination Cardiac Rehab Randomized Controlled Trial
Brewer, LaPrincess C. , Abraham, Helayna , Clark, Donald , Echols, Melvin , Hall, Michael E. , Hodgman, Karen, Kaihoi, Brian, Kopecky, Stephen L. , Krogman, Ashton , Leth, Shawn , Malik, Shaista , Scales, Robert , Schulte, Phillip J. , Shultz, Adam M. , Wong, Nathan D. , Olson, Thomas P. , Hall, Michael , Kopecky, Stephen L , Marsteller, Jill , Mathews, Lena , Scales, Robert , Schulte, Phillip , Shultz, Adam , Thomas, Randal , Wong, Nathan , Olson, Thomas , Brewer, LaPrincess C , Taylor, Bryan J. , Thomas, Randal J.

Journal of the American Heart Association | November 28, 2023 | Volume: 12 | Issue: 23 | Pages: No page available

10.1161/jaha.123.030883 Get It

Background Innovative restructuring of cardiac rehabilitation (CR) delivery remains critical to reduce barriers and improve access to diverse populations. Destination Cardiac Rehab is a novel virtual world technology‐based CR program delivered through the virtual world platform, Second Life, which previously demonstrated high acceptability as an extension of traditional center‐based CR. This study aims to evaluate efficacy and adherence of the virtual world–based CR program compared with center‐based CR within a community‐informed, implementation science framework. Methods Using a noninferiority, hybrid type 1 effectiveness‐implementation, randomized controlled trial, 150 patients with an eligible cardiovascular event will be recruited from 6 geographically diverse CR centers across the United States. Participants will be randomized 1:1 to either the 12‐week Destination Cardiac Rehab or the center‐based CR control groups. The primary efficacy outcome is a composite cardiovascular health score based on the American Heart Association Life's Essential 8 at 3 and 6 months. Adherence outcomes include CR session attendance and participation in exercise sessions. A diverse patient/caregiver/stakeholder advisory board was assembled to guide recruitment, implementation, and dissemination plans and to contextualize study findings. The institutional review board–approved randomized controlled trial will enroll and randomize patients to the intervention (or control group) in 3 consecutive waves/year over 3 years. The results will be published at data collection and analyses completion. Conclusions The Destination Cardiac Rehab randomized controlled trial tests an innovative and potentially scalable model to enhance CR participation and advance health equity. Our findings will inform the use of effective virtual CR programs to expand equitable access to diverse patient populations. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05897710.